Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 49 - 60 items out of 311 results
ILCN article
Dr. Kazuhiko Nakagawa Discusses RELAY Study Data, Implications for Practice
ILCN article
First Therapeutic Approval in 16 years for MPM
ILCN article
FDA Perspectives on the Use of Liquid Biopsy in NSCLC
ILCN article
Funding Opportunities for Innovative Multidisciplinary Cancer Research Teams
ILCN article
FDA Approves Pralsetinib for RET Fusion–Positive NSCLC
ILCN article
Huge Strides for Liquid Biopsy Assays with Two FDA Approvals
ILCN article
Dr. Harpreet Singh Discusses the Conduct of FDA Clinical Trials During the COVID-19 Pandemic
ILCN article
The Chen-Huang Center for EGFR-Mutant Lung Cancers Represents a ‘Concentrated and Focused Effort’ in Studying Th is Disease Subset
ILCN article
Lorlatinib in ROS1-Positive NSCLC: A Review of Recent Data
ILCN article
Timing of Immune Checkpoint Inhibitors With Respect to Molecular Testing in NSCLC
ILCN article
Anne-Marie Baird, BSc, PhD
ILCN article
A Roadmap to Improving Lung Cancer Care in the Middle East and North Africa
Pagination
First
First page
‹
Previous page
1
2
3
4
5
6
7
8
9
…
›
Next page
Last
Last page